Bind Research | Senior Scientist | Full-time | London, UK (ONSITE) | bindresearch.org
We are a UK-based not-for-profit Focused Research Organisation (FRO) committed to improving patient outcomes by turning disordered proteins into viable drug targets.
We are hiring across a number of roles in the areas of machine learning, biomolecular simulation, nuclear magnetic resonance spectroscopy, biochemistry, and protein production.
The great advantage of these tracers is that they target actual structures over-expressed in cancers, which means they show far higher specificity than something like FDG. That means they can be used to find micrometastases, and with a different radio-label also be applied for highly targeted radiation therapy.
Source: I used to work in the Heidelberg lab that published this study.
We are a UK-based not-for-profit Focused Research Organisation (FRO) committed to improving patient outcomes by turning disordered proteins into viable drug targets.
We are hiring across a number of roles in the areas of machine learning, biomolecular simulation, nuclear magnetic resonance spectroscopy, biochemistry, and protein production.
Find out more and apply here: https://bindresearch.org/careers/